Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Friday's Pre-Market Session

 

Gainers

  • Unity Biotechnology (NASDAQ:UBX) shares increased by 95.3% to $1.66 during Friday's pre-market session. The market value of their outstanding shares is at $114.8 million.
  • Rani Therapeutics Hldgs (NASDAQ:RANI) stock moved upwards by 23.08% to $10.13. The company's market cap stands at $248.1 million. As per the press release, Q2 earnings came out 2 days ago.
  • Larimar Therapeutics (NASDAQ:LRMR) stock rose 18.68% to $2.35. The company's market cap stands at $41.6 million. The company's, Q2 earnings came out yesterday.
  • LogicMark (NASDAQ:LGMK) stock increased by 13.44% to $1.35. The company's market cap stands at $12.9 million. The company's, Q2 earnings came out yesterday.
  • Neoleukin Therapeutics (NASDAQ:NLTX) shares increased by 12.74% to $1.15. The company's market cap stands at $48.9 million. As per the press release, Q2 earnings came out 3 days ago.
  • AirSculpt Technologies (NASDAQ:AIRS) shares moved upwards by 12.61% to $10.0. The company's market cap stands at $556.4 million. As per the news, the Q2 earnings report came out today.

Losers

  • Aptinyx (NASDAQ:APTX) shares fell 36.5% to $0.38 during Friday's pre-market session. The company's market cap stands at $25.8 million.
  • Co-Diagnostics (NASDAQ:CODX) stock decreased by 30.79% to $4.47. The market value of their outstanding shares is at $151.0 million. The company's, Q2 earnings came out yesterday.
  • PLx Pharma (NASDAQ:PLXP) stock fell 16.61% to $2.16. The company's market cap stands at $59.4 million. As per the news, the Q2 earnings report came out today.
  • Illumina (NASDAQ:ILMN) shares decreased by 15.52% to $192.15. The market value of their outstanding shares is at $30.1 billion. As per the press release, Q2 earnings came out yesterday.
  • Certara (NASDAQ:CERT) shares fell 14.62% to $17.24. The company's market cap stands at $2.7 billion. The company's, Q2 earnings came out 3 days ago.
  • AcelRx Pharmaceuticals (NASDAQ:ACRX) shares declined by 12.9% to $0.27. The company's market cap stands at $40.0 million. As per the news, the Q2 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.